APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 75 filers reported holding APTINYX INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -33.3% | 10,901 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -76.0% | 10,901 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -13.8% | 10,901 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | +11.5% | 10,901 | 0.0% | 0.00% | – |
| Q3 2021 | $26,000 | -16.1% | 10,901 | 0.0% | 0.00% | – |
| Q2 2021 | $31,000 | -6.1% | 10,901 | 0.0% | 0.00% | – |
| Q1 2021 | $33,000 | -13.2% | 10,901 | 0.0% | 0.00% | – |
| Q4 2020 | $38,000 | +2.7% | 10,901 | 0.0% | 0.00% | – |
| Q3 2020 | $37,000 | -17.8% | 10,901 | 0.0% | 0.00% | – |
| Q2 2020 | $45,000 | +32.4% | 10,901 | -31.4% | 0.00% | – |
| Q1 2020 | $34,000 | -37.0% | 15,901 | 0.0% | 0.00% | – |
| Q4 2019 | $54,000 | -1.8% | 15,901 | 0.0% | 0.00% | – |
| Q3 2019 | $55,000 | +3.8% | 15,901 | 0.0% | 0.00% | – |
| Q2 2019 | $53,000 | +20.5% | 15,901 | +45.9% | 0.00% | – |
| Q1 2019 | $44,000 | – | 10,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
| ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
| Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
| NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
| DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
| Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
| Orbimed Advisors | 538,500 | $300,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |